Earning Reports to Watch (Jan 28-Feb 01)

He shorted the name a couple of years ago, but has almost no position now.  It is highly speculative.  There is a lot of resource and it will take a lot of money to take it into production. (James Hodgins)

They haven't indicated a discovery in the St. James Bay area, though he likes the management and this part of the world for exploration.  (Rick Rule)

Cobalt is a partner commodity in the production of lithium batteries. Earnings are expected to be negative in 2019. Cobalt prices have risen sharply, causing manufacturers to find a way to move away from using it -- nickle may replace it (as an aside Sherritt could be a potential benefactor of this). He would consider…

Where it goes from here will depend on what they get from more drill results. Initial indications were very positive. (Lawrence Roulston)

They're financed to build their Eagle project in the Yukon, but it's low-grade. His exit strategy is for someone to take them out, but doubts it'll happen at current low gold prices. Brent Cook: Doesn't see anyone buying a modest-grade project like this. (Joe Mazumdar)

(Market call minute.) A microcap stock and will be a bet on much higher gold prices and their ability to navigate through the problems in Indonesia. (Brian Huen)

Has one of the better geologists in the Pacific Northwest. Focus on Lucky Shot is a mistake. Could find a joint venture partner who would come in and develop without them having to do it. Doesn't think they have the experience/capacity to develop it themselves. (Rick Rule)

Uranium assets and an optionality asset in the Athabascan Basin. It is priced in the company, probably for free. In the right uranium market, it won’t be free. Extremely well-run. Good optionality in gold. The company has had a tremendous run up. If you have owned this for a while, take a little bit off…

A global leader. Their EBITDA should bottom in Q1. They started their Chilean plant on time and on budget. They're buying back 5% of its share. It's trading below its historic multiple. It's a play on Brent oil and global growth. A tailwind is Iranian curtailment. You can hold this for a long time. But…

Forest products and home builders have done quite well over the last little bit. We are in the seasonal period for forest products and home building until the beginning of February. Charts looks positive. There is no resistance, the next level of resistance is around $20 or so. This is more of a momentum play…

Usually silver will lead gold by a little bit. Everything in silver right now is looking really, really good. Chart shows a downward pattern, but has reached the upper side of the channel and should be breaking out anytime now, and do quite well through to mid-March and maybe April, depending on the whole complex.…

(A Top Pick Mar 21/18, Down 8%) The world's largest producer of particle board. There has been a slow down in US housing. He has not seen a real bottom in lumber fundamentals yet. He sold it in June for a 3% loss. (Robert McWhirter)

(A Past Top Pick on April 26, 2017, Down 5%) They build student housing very well and there's currently a shortage in the west. They make a 10% EBITDA margin on these schools. In addition to revenues, they benefit from the asset value is rising in  those projects. They have several the Vancouver area. Down…

(A Top Pick Mar 29/18, Up 28%) They beat in Q4, earnings up nearly 16%. They can grow their earnings 15% compounded annually. (Greg Newman)

This had disappointing results. Had come to the Street about a year ago talking about their new high tech Japanese equipment. Their big business is making moulds for automobile engines. It’s a purchase that auto companies would only make once or twice in a cycle. They hadn’t delivered in the latest quarter and the stock…

(A Top Pick Apr 24/18, Up 9%) Not followed much, but he stands by this stock. A great business plan that managers have executed. A growth by acquisition story that has tripled its market cap to $500 million since he bought it. They do HR, admin and consulting. Done a great job integrating purchases. Their…

It is the best run of the grocery stores. They made an acquisition to get into delivery in the downtown core. Nice dividend yield and you can sleep at night. (Bruce Murray)

Edible Markets.  He researched the patent and it was created by two ladies in Florida.  It was for a tea.  He wants to know how it will work.  CBD oil mixed with fats won’t get past the liver to the blood stream.  He thinks there is a lot of upside in the edibles market but…

Involved in a duopoly in Canada. They bought a maple syrup company and debt levels went up. Sugar in Canada is a slow growth business and he is concerned about their payout ratio. (Michael Simpson, CFA)

Open Text vs CGI? The major difference is that one pays a dividend and one grows by acquisition. For these reasons he prefers OTEX-T for the 1.6% dividend. (Darren Sissons)

Reverse head and shoulders now? The problem is that the second one is lower than the first one. It's trending lower, but at least it has established a support level around $11. (Elliott Fishman)

Strong fundamentals, but it's running into resistance now. (Andrew Pyle)

()

Doesn't know this super well, but obviously with what is going on in the blockchain/Bitcoin space, this is a bit of a hybrid. They are doing a similar type of business in gold. You are seeing a big trend and big interest in that sector, but at the same time, you are also seeing gold…

This is a seasonal period when Lifecos in general tend to do well. This is a special vehicle where they buy a lifeco, split it up and give the capital appreciation to one half, and the dividend to the other half. Dividend yield of 19% is extremely high, and he is having trouble with that.…

This trades at low valuations – 12 times earnings.  A low cost producer in New Brunswick.  Yield 0%. (Analysts’ price target is $9.09) (Charles Taersk)

This is his first entry into the weed sector. These guys are extractors and therefore the margins are higher. They are just getting going in revenues and he expects they will be taken out. They have all their licences. Yield = 0.0% (Analysts’ price target is $5.63) (Jaime Carrasco)

A really interesting little company. Pretty small, but reminds him a lot of Nobilis Health (NHC-T), which was a Top Pick in the past. Have bought some ambulatory surgical centres in the New York State area, and they are going to continue to roll those up. These are typically started by doctor’s groups and are…

They have finally inked some very significant deals in the last 3 months, which is why the stock has doubled since then. Thinks there is pretty good opportunity. One of the challenges is that there is only one analyst covering it. (Robert McWhirter)

He would be looking for a turn relative to its group and relative to the market and neither of those two are happening. It has been having a difficult time generating a total return over the years. There are better places. (David Burrows)